hypogonadism; oral-t; kyzatrex; mens health

At the Clinical Application of Longevity Medicine 2026 conference, cardiologist and longevity physician Dr. Abid sits down with Shalin of Marius Pharmaceuticals — makers of Kyzatrex, the FDA-approved oral testosterone — for a candid conversation about the past, present, and future of...

Shalin Shah is the CEO of Marius Pharmaceuticals, where he leads the development of novel therapies for testosterone deficiency and metabolic health. His background spans finance, private equity, and pharmaceutical strategy, with a focus on patient-centered innovation and education around...